Naijian Ge

1.3k total citations
45 papers, 761 citations indexed

About

Naijian Ge is a scholar working on Hepatology, Materials Chemistry and Surgery. According to data from OpenAlex, Naijian Ge has authored 45 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 12 papers in Materials Chemistry and 10 papers in Surgery. Recurrent topics in Naijian Ge's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Layered Double Hydroxides Synthesis and Applications (9 papers) and Liver Disease and Transplantation (6 papers). Naijian Ge is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Layered Double Hydroxides Synthesis and Applications (9 papers) and Liver Disease and Transplantation (6 papers). Naijian Ge collaborates with scholars based in China, United States and Hong Kong. Naijian Ge's co-authors include Yefa Yang, Xuanyong Liu, Donghui Wang, Yuqin Qiao, Jinhua Li, Mengchao Wu, Jinliang Xing, Feng Peng, Hongqin Zhu and Lei Chen and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Naijian Ge

43 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naijian Ge China 18 192 181 170 151 149 45 761
Guofeng Zhou China 15 98 0.5× 216 1.2× 167 1.0× 259 1.7× 91 0.6× 48 786
Hongjun Yuan China 15 220 1.1× 64 0.4× 171 1.0× 365 2.4× 145 1.0× 34 818
Kun Qian China 13 189 1.0× 124 0.7× 85 0.5× 244 1.6× 144 1.0× 38 744
Ruomi Guo China 16 198 1.0× 62 0.3× 53 0.3× 175 1.2× 106 0.7× 53 728
Xiaopeng Yu China 15 307 1.6× 83 0.5× 48 0.3× 154 1.0× 81 0.5× 41 803
Dongwei Gao United States 19 211 1.1× 66 0.4× 38 0.2× 248 1.6× 42 0.3× 30 830
Hongyun Huang China 15 210 1.1× 83 0.5× 52 0.3× 175 1.2× 43 0.3× 43 680
Yu‐Fen Chung Taiwan 8 333 1.7× 342 1.9× 42 0.2× 84 0.6× 67 0.4× 11 917
Yuanxue Zhang China 7 170 0.9× 42 0.2× 423 2.5× 693 4.6× 26 0.2× 9 1.0k
Anna Degrassi Italy 17 226 1.2× 16 0.1× 59 0.3× 144 1.0× 145 1.0× 26 736

Countries citing papers authored by Naijian Ge

Since Specialization
Citations

This map shows the geographic impact of Naijian Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naijian Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naijian Ge more than expected).

Fields of papers citing papers by Naijian Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naijian Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naijian Ge. The network helps show where Naijian Ge may publish in the future.

Co-authorship network of co-authors of Naijian Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Naijian Ge. A scholar is included among the top collaborators of Naijian Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naijian Ge. Naijian Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Chao, Ji Tan, Hongqin Zhu, et al.. (2025). Plasma treated NiTi stents for antithrombosis and antibacterial infection by ammonia generation and surface charge regulation. Chemical Engineering Journal. 507. 160730–160730. 2 indexed citations
2.
Zhang, Haifeng, et al.. (2024). Selective Tumor Inhibition Effect of Drug-Free Layered Double Hydroxide-Based Films via Responding to Acidic Microenvironment. ACS Biomaterials Science & Engineering. 10(8). 4927–4937.
3.
Li, Jing, Jingyi Xu, Yue Chen, et al.. (2024). Fusible and Radiopaque Microspheres for Embolization. Advanced Materials. 36(39). e2405224–e2405224. 6 indexed citations
4.
Zhou, Jing, et al.. (2024). Massive gastrointestinal hemorrhage and iodine-125 seed migration due to hepatogastric fistula: a case report and literature review. Translational Cancer Research. 13(11). 6584–6589. 1 indexed citations
5.
Wang, Donghui, Haifeng Zhang, Lidan Liu, et al.. (2023). Tumor microenvironment‐responsive arsenic‐loaded layered double hydroxides film with synergistic anticancer and bactericidal activity. Rare Metals. 43(3). 1207–1221. 7 indexed citations
6.
Ge, Naijian, et al.. (2023). Optimal interventional treatment for liver cancer: HAIC, TACE or iTACE?. SHILAP Revista de lepidopterología. 6(2). 59–63. 5 indexed citations
7.
Ge, Naijian, et al.. (2022). Portal vein embolization in the treatment of portal vein bleeding after percutaneous transhepatic biliary drainage: A case report and literature review. SHILAP Revista de lepidopterología. 5(4). 217–220. 2 indexed citations
9.
Tan, Ji, et al.. (2022). Biological Property Investigation of Nitinol Surface Implanted with Tantalum. Journal of Inorganic Materials. 37(11). 1217–1217.
10.
Wang, Xiangdong, et al.. (2022). Endovascular treatment for delayed post-pancreaticoduodenectomy hemorrhage of unusual origin (splenic artery branch). Journal of Vascular Surgery Cases and Innovative Techniques. 8(4). 865–871. 1 indexed citations
11.
Xu, Ru, Dongdong Zhang, Ji Tan, et al.. (2022). A multifunctional cascade bioreactor based on a layered double oxides composite hydrogel for synergetic tumor chemodynamic/starvation/photothermal therapy. Acta Biomaterialia. 153. 494–504. 25 indexed citations
13.
Huang, Jian, et al.. (2021). Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by pembrolizumab: A case report. World Journal of Clinical Cases. 9(10). 2281–2288. 7 indexed citations
14.
Long, Xiaoyu, Xiaoyan Wang, Yibing Chen, et al.. (2017). Polymorphisms in POLG were associated with the prognosis and mtDNA content in hepatocellular carcinoma patients. Bulletin du Cancer. 104(6). 500–507. 4 indexed citations
15.
Bao, Dengke, Yanna Ba, Feng Zhou, et al.. (2016). Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. Cancer Chemotherapy and Pharmacology. 78(4). 791–799. 17 indexed citations
16.
Ge, Naijian, Zhiyong Shi, Xiao‐Jun Huang, et al.. (2015). Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early-Stage Hepatocelluar Carcinoma. Asian Pacific Journal of Cancer Prevention. 16(9). 4103–4107. 6 indexed citations
18.
Wu, Lu, Yefa Yang, Naijian Ge, et al.. (2012). Hepatic artery injection of 131I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study. European Journal of Nuclear Medicine and Molecular Imaging. 39(8). 1306–1315. 26 indexed citations
19.
Lu, Jianguo, Han-Qiang Liu, Xu Guo, et al.. (2012). A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma. Liver International. 32(9). 1451–1459. 42 indexed citations
20.
Zhao, Siyuan, Yefa Yang, Juan Liu, et al.. (2011). Association of mitochondrial DNA content in peripheral blood leukocyte with hepatitis B virus‐related hepatocellular carcinoma in a Chinese Han population. Cancer Science. 102(8). 1553–1558. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026